Labshake search
Citations for Stemcell Technologies :
351 - 400 of 982 citations for 10 14 Cadinene 4 5 Diol since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... incubated with DNase I (10 μg/ml; STEMCELL Technologies) for 10 min at room temperature ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 10 ng/ml bFGF (STEMCELL Technologies, cat# 02634) in a humidified 37°C ...
-
bioRxiv - Genomics 2024Quote: ... and 10 µM ROCK inhibitor Y-27632 (STEMCELL Technologies), and then adapted to the feeder-free culture ...
-
bioRxiv - Neuroscience 2024Quote: ... Rock inhibitor (10 μM, Y-27632, STEMCELL Technologies, Canada) was included in the medium in the first 24 hours of culture ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 10 µg/ml DNase I (StemCell Technologies, #07900)] through the trachea and then finely minced ...
-
bioRxiv - Neuroscience 2024Quote: ... containing 10 µM Y- 27632 (cat#: 72302; StemCell Technologies) and 100 µg/mL of the antibiotic Primocin (cat# ...
-
bioRxiv - Physiology 2024Quote: ... supplemented with 10 µM Y-27632 (StemCell Technologies, 72304). Forty-eight hours after plating ...
-
bioRxiv - Molecular Biology 2024Quote: ... and Y-27632 (Stem Cell Technologies, #72307; 10 μM). Media was replaced with normal growth (ENR ...
-
bioRxiv - Neuroscience 2024Quote: ... Cat # 17502048)] supplemented with SB431542 (10 μM, Stemcell Technologies, Cat # 72234), XAV939 (2 μM ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10 mM ROCK inhibitor Y27632 (Stem Cell Technologies) (subsequently referred to as ‘maturation media’) ...
-
bioRxiv - Neuroscience 2024Quote: ... Cat # 07156)] supplemented with SB431542 (10 μM, Stemcell Technologies, Cat # 72234), XAV939 (2 μM ...
-
bioRxiv - Cell Biology 2024Quote: ... 10 μM Rho-kinase inhibitor Y27632 (Stemcell Technologies, 72308) and 20 μg/mL Gentamicin was used to resuspend and plate cyrpts in sterile 24-well non-treated tissue culture plates (Falcon ...
-
bioRxiv - Cell Biology 2024Quote: ... with 10 μM Y-23632 (Rock inhibiter, STEMCELL technologies) for the first day after passages and subcultured every 5–7 days using ReLeSR reagent (STEMCELL Technologies) ...
-
bioRxiv - Neuroscience 2021Quote: ... iPSCs were fed daily and split every 4-7 days using ReLeSR (StemCell Technologies) according to manufacturer’s instructions ...
-
bioRxiv - Cell Biology 2020Quote: ... were incubated overnight at 4° C with anti-CD3 (Clone UCHT1, StemCell Technologies, #60011) 10 μg/mL in PBS ...
-
bioRxiv - Genetics 2021Quote: ... iPSC cultures were passaged every 3-4 days with Accutase (Stem Cell Technologies, 07920) or ReLeSR (Stem Cell Technologies ...
-
bioRxiv - Developmental Biology 2023Quote: ... after which 4 ml maturation medium (Cerebral organoid kit, cat. n. 08570, StemCell Technologies) were gently added to each well ...
-
bioRxiv - Cell Biology 2023Quote: ... On days 4 and 6 LDM medium with added 50ng/ml BMP4 (STEMCELL Technologies) and 6ul/ml DMSO was used ...
-
bioRxiv - Genetics 2020Quote: ... Transduced cells were expanded to 10 cm plates and 10 vials (2M cells/vial) of each cell line was cryopreserved in CryoStor® (StemCell Technologies, 07930) for further use.
-
bioRxiv - Cell Biology 2024Quote: ... HPNE cells were grown in a 3:1 mixture of DMEM+GlutaMAX: Medium M3 Base supplemented with 10% FBS and 10 ng/ml human recombinant EGF (StemCell Technologies Inc. 78006). HUVEC and TeloHAEC derived cell lines were grown in Vascular Cell Basal Medium supplemented with the Vascular Endothelial Cell Growth Kit-VEGF (ATCC PCS-100-041) ...
-
bioRxiv - Physiology 2020Quote: ... Undifferentiated hiPSCs were maintained on Vitronectin XF (5 μg/mL, Stem Cell Technologies) coated tissue culture dishes as per manufacturer recommendation with either mTeSR medium with supplementation or mTeSR PLUS medium with supplementation (Stem Cell Technologies) ...
-
bioRxiv - Developmental Biology 2021Quote: ... 300 U/mL of hyaluronidase and 5 mg/mL DNAse I (StemCell Technologies) under gentile agitation for 10 min ...
-
bioRxiv - Developmental Biology 2021Quote: ... 300 U/mL of hyaluronidase and 5 mg/mL DNAse I (StemCell Technologies) under gentile agitation for 10 min ...
-
bioRxiv - Neuroscience 2024Quote: ... and passaged every 3-5 days using ReLeSR™ (#05872; Stem Cell Technology).
-
bioRxiv - Cancer Biology 2023Quote: ... pelleted cells were resuspended with pre-warmed 5 mg/ml dispase (STEMCELL Technologies) supplemented with 1:10 dilution of 1 mg/ml DNase I (STEMCELL Technologies) ...
-
bioRxiv - Molecular Biology 2023Quote: ... supplemented with a final concentration of 5 μM XAV-939 (STEMCELL Technologies, #72672) on 1:100 geltrex (GIBCO ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were passaged every 4 to 7 days with ReLeSR reagent (StemCell Technologies catalog #05872) to ensure that only undifferentiated stem cells remained in the cultures ...
-
bioRxiv - Genomics 2021Quote: ... and 4) one cord blood (CB001) collected with informed consent by StemCell Technologies (catalog #70007) (Table S1) ...
-
bioRxiv - Cancer Biology 2023Quote: Primary cells are resuspended in a 3:4 solution of Mammocult medium (Stem Cell Technology) and Matrigel (Corning)17,26,29 ...
-
bioRxiv - Cell Biology 2024Quote: ... The cells were passaged every 3-4 days by dissociating them using Accutase (STEMCELL Technologies) according to manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2024Quote: ... Common Rule (Category 4) or 2) de-identified donor leukapheresis products obtained from StemCell Technologies. CD3+ T-cell populations were isolated using RosetteSep Human T Cell Enrichment Cocktails (Stemcell Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... Common Rule (Category 4) or 2) de-identified donor leukapheresis products obtained from StemCell Technologies. CD3+ T-cell populations were isolated using EasySep Human T Cell Isolation Kit (StemCell Technologies ...
-
bioRxiv - Bioengineering 2023Quote: ... and passaged every 3-4 days using Gentle Cell Dissociation Reagent (STEMCELL Technologies, 100-0485) for clump passaging ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were passaged every 4 days by non-enzymatic dissociation with ReLeSR (StemCell Technologies Inc.) and plated at a density of 5.0×105 per 60 mm plate.
-
bioRxiv - Cancer Biology 2024Quote: 200-500 edited residual HSCs were added to 4 mL of MethoCult H4435 (Stemcell Technologies) and differentiated for 14 days ...
-
bioRxiv - Genetics 2024Quote: ... every other day and passaged every 3–4 days with Accutase (Stem Cell Technologies 07920) or ReLeSR (Stem Cell Technologies 100-0483) ...
-
bioRxiv - Cancer Biology 2020Quote: ... epidermal growth factor (EGF, 10 ng/ml; Stem Cell Technology) and basic fibroblast growth factor (bFGF ...
-
bioRxiv - Microbiology 2021Quote: ... in mTeSR Plus with 10 mM Y-27632 (STEMCELL Technologies). The next day ...
-
bioRxiv - Immunology 2022Quote: ... and recombinant human EGF (10 ug/mL; Stem Cell Technologies) in 10% DMSO before long-term cryopreservation (1X107 cells/mL ...
-
bioRxiv - Microbiology 2020Quote: ... and in mTeSR1 with 10 µM Y-27632 (Stemcell technologies). The next day ...
-
bioRxiv - Cancer Biology 2022Quote: ... heparin sulfate (10 ng/ml; 100-18B, STEMCELL Technologies, USA), and 5% human serum (#H4522-100ML ...
-
bioRxiv - Immunology 2020Quote: ... and 25 ng/ml IL-10 (STEMCELL Technologies, Vancouver, Canada). After stimulation ...
-
bioRxiv - Genomics 2021Quote: ... and 10 µM ROCK inhibitor Y-27632 (STEMCELL Technologies, 72302). HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium (Gibco ...
-
bioRxiv - Genomics 2020Quote: ... and 10-20 μg/mL DNAse I (StemCell Technologies, #7900) for 5-10 min in a 37°C water bath with intermittent mixing ...
-
bioRxiv - Systems Biology 2023Quote: ... at 10 µM and LDN-193189 (72147 Stem Cell Technologies) at 100 nM) ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with 10 μM Y-27632 (Stemcell Technologies, Vancouver, Canada) for the first 24h of culture ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10-6 M hydrocortisone (74142, Stem Cell Technologies) and 1% penicillin streptomycin ...
-
bioRxiv - Cancer Biology 2024Quote: ... supplemented with 10% MammoCult Proliferation Supplement (StemCell Technologies Cat#05622), 1% hydrocortisone stock solution (StemCell Technologies Cat#07925) ...
-
bioRxiv - Cancer Biology 2024Quote: ... penicillin–streptomycin and 10% gentle collagenase/hyaluronidase (StemCell Technologies, 07919). After vortexing ...
-
bioRxiv - Genomics 2024Quote: ... 1 µM doxycycline and 10% CloneR™ (StemCell Technologies #05888) in mTeSR medium ...